GlassScriptPhysician profile
Arvin Bansal
NPI 1417278821
$2,663.79
in general payments reported to CMS, 2019-2025
18 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $150 · 2021: $299 · 2022: $400 · 2023: $531 · 2024: $188 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $605.82 | 2019-2025 | Mylux Patient Kit With Mobile Device |
| Impulse Dynamics (USA) INC. | $481.14 | 2023-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $387.64 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $275.24 | 2019-2025 | |
| Abbott Laboratories | $224.57 | 2019-2022 | |
| Medtronic Vascular, INC. | $122.98 | 2019 | |
| Edwards Lifesciences Corporation | $119.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $94.63 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $72.49 | 2022-2025 | |
| Medtronic, INC. | $41.69 | 2021 | |
| Pfizer INC. | $41.41 | 2023 | |
| Amgen INC. | $38.86 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $35.94 | 2023-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.20 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $31.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $31.08 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $15.69 | 2020 | |
| Zoll Circulation INC | $9.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvin Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.